MGD011, a CD19 x CD3 Dual Affinity Re-Targeting Bi-specific Molecule Incorporating Extended Circulating Half-life for the Treatment of B-cell Malignancies

Liu, L.; Lam, C.-Y. K.; Long, V.; Widjaja, L.; Yang, Y.; Li, H.; Jin, L.; Burke, S.; Gorlatov, S.; Brown, J.; Alderson, R.; Lewis, M. D.; Nordstrom, J. L.; Koenig, S.; Moore, P. A.; Johnson, S.; Bonvini, E.

期刊名称Clinical Cancer Research
作者Liu, L.; Lam, C.-Y. K.; Long, V.; Widjaja, L.; Yang, Y.; Li, H.; Jin, L.; Burke, S.; Gorlatov, S.; Brown, J.; Alderson, R.; Lewis, M. D.; Nordstrom, J. L.; Koenig, S.; Moore, P. A.; Johnson, S.; Bonvini, E.
印刷ISSN1078-0432
电子ISSN1557-3265
文件大小3329.03KB
发表时间2016-09-23
DOI10.1158/1078-0432.CCR-16-0666

发现好书期刊，享受阅读乐趣

MGD011, a CD19 x CD3 Dual Affinity Re-Targeting Bi-specific Molecule Incorporating Extended Circulating Half-life for the Treatment of B-cell Malignancies